van den Bent, M., Eoli, M., Sepulveda, J. M., Smits, M., Walenkamp, A., Frenel, J., . . . Golfinopoulos, V. (2020). Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Neuro Oncol.
Citação norma Chicagovan den Bent, Martin, et al. "Corrigendum to INTELLANCE 2/EORTC 1410 Randomized Phase II Study of Depatux-M Alone and With Temozolomide Vs Temozolomide or Lomustine in Recurrent EGFR Amplified Glioblastoma." Neuro Oncol 2020.
Citação norma MLAvan den Bent, Martin, et al. "Corrigendum to INTELLANCE 2/EORTC 1410 Randomized Phase II Study of Depatux-M Alone and With Temozolomide Vs Temozolomide or Lomustine in Recurrent EGFR Amplified Glioblastoma." Neuro Oncol 2020.